HTFL: HeartFlow Inc Net earnings per share for the last 12 months

Public company logo of heartflow.com (HTFL)

Heartflow Inc operates in the stable cardiology sector with minimal geopolitical threats. Annual net income per share on GURU.Markets demonstrates the impact of a cloud-based SaaS approach to 3D blood flow modeling. Growth is driven by insurance coverage and the implementation of AI diagnostics in clinics, while the -1.39 level serves as a critical benchmark for assessing the business's financial efficiency.

HTFL (HeartFlow) Earnings per one share for the last 12 months history from 08/09/2025 to 11/10/2026

Analytical breakdowns and data insights for company HeartFlow Corp (HTFL)

- current quotes and average value forecast:
Price Chart HeartFlow, Inc.|HTFL - Fair Value Consensus
- market capitalization information:
Market Valuation HeartFlow, Inc.|HTFL - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share HeartFlow|HTFL - Net Asset Value|Market Value to Book Value Ratio heartflow.com|HTFL - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Heartflow Inc|HTFL - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio HeartFlow Medical|HTFL - Company Total Debt|Debt to Book Value HeartFlow, Inc.|HTFL - Company Long-Term Loans and Borrowings|Company Short-Term Debts HeartFlow|Quick Liquidity heartflow.com
- net income and valuation multiples indicators:
HTFL - Company Profit|Projected Future Earnings Heartflow Inc|HTFL - Price to Earnings Ratio|Forward P/E Multiple HeartFlow|HTFL - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio HeartFlow, Inc.|HTFL - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) HeartFlow|HTFL - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months heartflow.com|HTFL - Earnings per share growth in current year|Earnings growth forecast for next year Heartflow Inc
Initial company analysis:heartflow.com - HTFL
Mass-produced product of Heartflow Inc

To isolate the fundamental stability of Heartflow Inc (HTFL) from market noise, EPS TTM is utilized to measure the actual earnings per share over a year, excluding accounting manipulations. The current value of -1.39, represented by the rolling 12-month net income per share, confirms the efficiency of the cloud AI diagnostics model, which reduces operating expenses by eliminating invasive procedures and hazardous waste.

Competing companies

REGN - Earnings per share for the last twelve months|Earnings per share for the trailing year IRTC (irhythmtech.com)|LNTH (Lantheus) - Net earnings per share for the last 12 months|MLYS: Earnings per share for the last four quarters|KMTS (Kestra) - Net earnings per share (EPS TTM)|Esperion Corp - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Amarin Corporation plc (AMRN)|Earnings per share for the last twelve months AVR (anteristech.com)|Earnings per share for the last twelve months Tenaya Therapeutics, Inc. TNYA|CVRx Inc. (CVRX) - Net earnings per one share for the last twelve months|MIST: Net earnings per share for the last 12 months|Cardiol Therapeutics (CRDL) - Net earnings per share for the last 12 months|BEAT (HeartBeam, Inc.) - Net earnings per share for the last 12 months|tenaxthera.com - Earnings per share for the trailing year|ADGM (Adagio Medical) - Net earnings per share (EPS TTM)|BioCardia Inc. (BCDA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Catheter Precision Corp (VTAK)|arcabio.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ACST (Acasti Pharma Inc.)|AVTE - Net earnings per share for the last 12 months|Verve - Net earnings per share (EPS TTM)|Earnings per share for the trailing year WINT (Windtree Therapeutics)